December 9, 2020

A milestone is reached with the inclusion
of 440 patients in the AGENT study

Link to the press release >>

November 2, 2020

Isofol announces licensing agreement for Paladin Labs Inc. to commercialize arfolitixorin in Canada

Link to the press release >>

See how arfolitixorin
works in cancer cells

See the animation >>



Startpage 2